GlassScriptPhysician profile
William G Cheadle
NPI 1427037076
$3,329.67
in general payments reported to CMS, 2019-2025
26 companies · $660 in 2025
The $660 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $293 · 2020: $181 · 2021: $224 · 2022: $389 · 2023: $560 · 2024: $1,024 · 2025: $660.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,244.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $566.67 | 2022-2024 | Gore Tag Conformable Thoracic Endoprosthesis, Gore Synecor Biomaterial |
| Smith+Nephew, INC. | $511.60 | 2024-2025 | Stravix, Grafix, Oasis |
| Boston Scientific Corporation | $266.77 | 2022-2023 | |
| Medtronic, INC. | $257.21 | 2021-2024 | Endurant Iis |
| Allergan, INC. | $239.66 | 2019 | |
| Tela Bio, INC. | $223.29 | 2019-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Orthofix Medical, INC. | $186.40 | 2025 | Truelok Evo |
| Acera Surgical, INC. | $157.00 | 2023 | Restrata Wound Matrix |
| Bioventus LLC | $151.03 | 2023 | |
| Integra Lifesciences Corporation | $121.01 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Terumo Medical Corporation | $117.24 | 2024 | Angio-Seal, Glidewire, Azur Cx Detachable |
| Baxter Healthcare | $101.97 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $87.53 | 2023-2025 | Pristine |
| Merck Sharp & Dohme LLC | $79.92 | 2023-2025 | Lynparza, Keytruda |
| Covidien LP | $49.98 | 2020 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $29.40 | 2025 | Limflow System |
| Kerecis Limited | $27.90 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Solventum Corporation | $24.66 | 2025 | Activ.A.C. |
| Abbvie INC. | $21.62 | 2024 | |
| Royal Biologics, INC. | $20.75 | 2025 | |
| Melinta Therapeutics, LLC | $18.21 | 2023 | Orbactiv, Kimyrsa |
| Atricure, INC. | $17.51 | 2024 | |
| Shire North American Group INC | $17.08 | 2019 | |
| Reprise Biomedical, INC. | $15.00 | 2025 | Miro3d |
| Pfizer INC. | $11.35 | 2019 | |
| Cardiovascular Systems INC. | $8.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cheadle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.